Analysis of Atrion (NASDAQ:ATRI) and ShockWave Medical (NASDAQ:SWAV)



Atrium (NASDAQ:ATRIGet a rating) and ShockWave Medical (NASDAQ: SWAVGet a rating) are two medical companies, but which is the best investment? We will compare the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and profitability.

Volatility and risk

Atrion has a beta of 0.18, indicating that its stock price is 82% less volatile than the S&P 500. In comparison, ShockWave Medical has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500.

Analyst Notes

This is a breakdown of recent recommendations for Atrion and ShockWave Medical, as reported by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
atrion 0 0 0 0 N / A
Medical ShockWave 0 1 5 0 2.83

ShockWave Medical has a consensus price target of $207.86, suggesting a potential upside of 10.06%. Given ShockWave Medical’s possible higher upside, analysts clearly believe that ShockWave Medical is more favorable than Atrion.

Institutional and insider ownership

77.4% of Atrion’s shares are held by institutional investors. By comparison, 89.1% of ShockWave Medical shares are held by institutional investors. 22.7% of Atrion’s shares are held by insiders. By comparison, 15.3% of ShockWave Medical’s stock is held by insiders. Strong institutional ownership indicates that large fund managers, hedge funds, and endowments believe a stock is poised for long-term growth.

Profitability

This table compares the net margins, return on equity and return on assets of Atrion and ShockWave Medical.

Net margins Return on equity return on assets
atrion 19.56% 13.94% 12.58%
Medical ShockWave 9.70% 12.36% 8.96%

Benefits and evaluation

This table compares the gross revenue, earnings per share and valuation of Atrion and ShockWave Medical.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
atrion $165.01 million 6.71 $33.06 million $18.67 32.94
Medical ShockWave $237.15 million 28.50 -9.14 million dollars $0.77 245.27

Atrion has higher revenue, but lower revenue than ShockWave Medical. Atrion trades at a lower price-to-earnings ratio than ShockWave Medical, indicating that it is currently the more affordable of the two stocks.

Summary

ShockWave Medical beats Atrion on 7 out of 13 factors compared between the two stocks.

About Atrion (Get a rating)

Atrion Corporation, together with its subsidiaries, develops, manufactures and sells products for fluid delivery, cardiovascular and ophthalmic applications in the United States, Canada, Europe and internationally. Its fluid delivery products include valves that fill, hold and release controlled amounts of fluids or gases for use in a variety of intubation, intravenous, catheter and other applications in the fields of anesthesia and oncology, as well as to promote infection control in hospitals and home care. environments. The Company’s cardiovascular products include the Myocardial Protection System that delivers fluids and medications and mixes critical medications, as well as monitors temperature, pressure and other variables; pressure relief valves for cardiac surgery; silicone vascular loops to retract and occlude vessels; and inflation devices for balloon catheter dilation, stent deployment and fluid delivery, as well as products for use in cardiac bypass surgery. Its ophthalmic products include specialty medical devices that disinfect contact lenses; and a range of balloon catheters, which are used for the treatment of nasal lacrimal duct obstruction in children and adults. The company also manufactures instruments and related disposable products that measure activated blood clotting time; and products for the safe containment of needles and scalpel blades. In addition, it manufactures inflation systems and valves used in maritime and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to doctors, hospitals, clinics and other treatment centers; and other equipment manufacturers through a direct sales force, independent sales representatives and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

About ShockWave Medical (Get a rating)

ShockWave Medical LogoShockWave Medical, Inc., a medical device company, engages in the development and commercialization of intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve disease in the whole world. The company offers M5 catheters for the treatment of peripheral arterial disease (PAD) above the knee; C2 catheters for the treatment of coronary heart disease; and S4 catheters for the treatment of PAD below the knee. It serves interventional cardiologists, vascular surgeons and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is based in Santa Clara, California.



Get news and reviews for Atrion Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Atrion and related companies with MarketBeat.com’s FREE daily email newsletter.

Previous Food Network 'Cupcake Lady' used identity of dead 'Baby Brie' to get loans, tuition and over $1 million in Covid relief - Crime Online
Next Global Powered Air Purifying Respirator (PAPR) Market Research Report 2022-2028 | Honeywell International, 3M Company, Dragerwerk AG & Co. KGaA, Kimberly-Clark Corporation, Mine Safety Appliances (MSA) Company, etc. – Instant Interview